Esperion to Participate in Upcoming Virtual J.P. Morgan 40th Annual Healthcare Conference
Esperion (NASDAQ: ESPR) announced that President and CEO Sheldon Koenig will present at the J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Esperion (NASDAQ: ESPR) announced that President and CEO Sheldon Koenig will present at the J.P. Morgan 40th Annual Healthcare Conference on January 13, 2022, at 10:30 a.m. ET. The presentation will include a live audio webcast available on the company's investor relations website, with replays archived for 90 days. Esperion focuses on lipid management, developing innovative medicines to lower cholesterol for patients underserved by existing solutions. More details can be found at www.esperion.com.
Details
News Market Reaction – ESPR
The recorded move for ESPR in the trading session of this news was -8.19%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ANN ARBOR, Mich., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming virtual J.P. Morgan 40th Annual Healthcare Conference on Thursday, January 13, 2022 at 10:30 a.m. Eastern Time.
| Event: | J.P. Morgan 40th Annual Healthcare Conference |
| Date: | Thursday, January 13, 2022 |
| Format: | Presentation and 1:1 Meetings |
| Time: | 10:30 a.m. ET |
Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.
Esperion Therapeutics
Esperion is The Lipid Management Company. Our goal is lipid management for everybody, that’s why we work hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.
Investor Contact:
Kaitlyn Brosco
Esperion
corporateteam@esperion.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.